A combination therapy
Meet TALZENNA
TALZENNA is a prescription medicine used in combination with a medicine called enzalutamide, to treat adults with prostate cancer
- with certain abnormal inherited or acquired genes called homologous recombination repair (HRR genes) and
- which no longer responds to hormone therapy or surgical treatment to lower testosterone and has spread to other parts of the body (metastatic).
This is also called homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).
Overall survival results
Find out more about how TALZENNA® + XTANDI® may help
Follow Paul on his path forward through treatment
Once-daily oral treatment
TALZENNA is a pill—not chemotherapy or an injection. It’s taken:
Once a day
With or without food
Learn more about how to take TALZENNA.
MyTherapy® app
Customized with TALZENNA content to support you on your treatment journey. It's available on the App Store and Google Play and includes:
Medication reminders
Manage your medications in one place and stay on top of your TALZENNA therapy with personalized reminders.
Support
Find additional support services and tools.
Education
Get informed about your treatment with articles and content. Plus, information about side effects.
Progress tracker
Discover ways to stay on track—set reminders, log habits, and record progress. You can also download your health report to discuss with your doctor at your next appointment.
App Store is a service mark of Apple Inc., registered in the US and other countries. Google Play and the Google Play logo are trademarks of Google LLC.